国泰上证科创板综合ETF
Search documents
机构风向标 | 芯导科技(688230)2025年三季度已披露持仓机构仅6家
Xin Lang Cai Jing· 2025-10-31 02:37
Group 1 - Core viewpoint: Chip导科技 (688230.SH) reported its Q3 2025 results, highlighting significant institutional and public fund holdings [1] - As of October 30, 2025, six institutional investors disclosed holdings in Chip导科技, totaling 54.2185 million shares, which represents 46.10% of the company's total equity [1] - The institutional holding percentage decreased by 0.28 percentage points compared to the previous quarter [1] Group 2 - One new public fund disclosed this quarter, namely 华夏国证2000指数增强发起式A [1] - A total of 39 public funds were not disclosed this quarter, including various ETFs and bond funds [1] - In terms of foreign investment, Goldman Sachs LLC was the only foreign institution that was not disclosed this quarter [2]
机构风向标 | 唯赛勃(688718)2025年三季度已披露持仓机构仅3家
Xin Lang Cai Jing· 2025-10-30 01:12
Core Insights - The report indicates that as of October 29, 2025, institutional investors hold a total of 117 million shares of Weisaibo (688718.SH), representing 67.06% of the company's total equity, with a slight decrease of 0.69 percentage points from the previous quarter [1] Institutional Holdings - Three institutional investors disclosed their holdings in Weisaibo, including Weisaibo Environmental Materials Holdings Limited, Shanghai Huajia Enterprise Management Partnership (Limited Partnership), and Shanghai Jingri Enterprise Management Partnership (Limited Partnership) [1] - The total institutional holding percentage has decreased by 0.69 percentage points compared to the last quarter [1] Public Fund Activity - A total of 54 public funds were not disclosed in this period compared to the previous quarter, including notable funds such as Huaxia CSI 500 Index Enhanced A, Guotai SSE STAR Market Comprehensive ETF, and Huaxia Smart Vanguard Stock (LOF) A [1] Foreign Investment - One new foreign institutional investor disclosed its holdings this quarter, which is Weisaibo Environmental Materials Holdings Limited [1] - The same foreign institutional investor was not disclosed in the previous quarter [1]
机构风向标 | 天富龙(603406)2025年三季度已披露前十大机构累计持仓占比3.38%
Xin Lang Cai Jing· 2025-10-29 02:17
Core Viewpoint - Tianfulong (603406.SH) reported its Q3 2025 results, highlighting a significant increase in institutional ownership and the involvement of various public funds [1] Group 1: Institutional Ownership - As of October 28, 2025, 32 institutional investors disclosed holdings in Tianfulong A-shares, totaling 13.5348 million shares, which represents 3.38% of the company's total share capital [1] - The top ten institutional investors collectively hold 3.38% of the shares, with a notable increase of 3.38 percentage points compared to the previous quarter [1] Group 2: Public Funds - In this reporting period, 29 new public funds were disclosed, including notable funds such as Guolian CSI A50 ETF, Huashan SSE 180 ETF, and others [1]
机构风向标 | 菲沃泰(688371)2025年三季度已披露前十大机构持股比例合计下跌3.22个百分点
Xin Lang Cai Jing· 2025-10-25 03:00
Core Insights - Favored Tech Corporation Limited (菲沃泰) reported its Q3 2025 financial results, revealing that as of October 24, 2025, seven institutional investors held a total of 233 million shares, representing 69.41% of the company's total equity [1] - The institutional ownership percentage decreased by 3.22 percentage points compared to the previous quarter [1] Institutional Investors - The institutional investors include Favored Tech Corporation Limited, Wuxi Fina Enterprise Management Partnership, Shenzhen China Resources Capital Equity Investment, China Construction Bank's Guoshou Anbao Smart Life Fund, Qingdao Yirong United Equity Investment Management Center, Shanghai Fuhe Private Fund Management, and Beijing Woyan Capital Management Center [1] - The total institutional ownership is significant, indicating strong interest from major investment entities [1] Public Funds - In this reporting period, 89 public funds were disclosed, including notable funds such as Southern Zhihong Mixed A, Guotai Shanghai Composite ETF, and Jianxin Shanghai Composite Smart Selection Sci-Tech Innovation Value ETF [1] - The absence of previously disclosed public funds suggests a shift in investment strategies or market conditions [1]
百利天恒股价涨5.39%,国泰基金旗下1只基金重仓,持有6.32万股浮盈赚取118.13万元
Xin Lang Cai Jing· 2025-09-02 02:59
Group 1 - The core viewpoint of the news is that Baili Tianheng's stock price increased by 5.39% to 365.70 CNY per share, with a trading volume of 386 million CNY and a turnover rate of 1.07%, resulting in a total market capitalization of 146.646 billion CNY [1] - Baili Tianheng Pharmaceutical Co., Ltd. is located in Chengdu, Sichuan Province, and was established on August 17, 2006, with its listing date on January 6, 2023. The company's main business involves the research, production, and sales of pharmaceuticals [1] - The revenue composition of Baili Tianheng shows that 99.57% is recognized at a specific point in time, while 0.43% is recognized over a specific period [1] Group 2 - From the perspective of major fund holdings, one fund under Guotai Fund has a significant position in Baili Tianheng. The Guotai SSE STAR Market Comprehensive ETF (589630) held 63,200 shares in the second quarter, accounting for 1.64% of the fund's net value, making it the sixth-largest holding [2] - The Guotai SSE STAR Market Comprehensive ETF (589630) has a current scale of 1.141 billion CNY and has achieved a return of 30.91% since its inception on March 4, 2025 [2] Group 3 - The fund managers of the Guotai SSE STAR Market Comprehensive ETF (589630) are Ma Yiwen and Liu Fangyuan. Ma Yiwen has a cumulative tenure of 2 years and 27 days, with the fund's total asset size at 6.894 billion CNY, achieving a best return of 86.18% and a worst return of 2.44% during the tenure [3] - Liu Fangyuan has a cumulative tenure of 145 days, with the fund's total asset size at 2.677 billion CNY, achieving a best return of 43.15% and a worst return of 17.78% during the tenure [3]
两市ETF两融余额较上一日减少1.73亿元
Zheng Quan Shi Bao Wang· 2025-08-18 01:56
Core Viewpoint - The latest ETF margin balance in the two markets is 100.148 billion yuan, showing a decrease of 1.73 billion yuan compared to the previous trading day, indicating a slight decline in market activity [1] Group 1: ETF Margin Balance Overview - As of August 15, the total ETF margin balance is 100.148 billion yuan, down 1.73 billion yuan or 0.17% from the previous day [1] - The financing balance for ETFs is 93.908 billion yuan, a decrease of 1.80 billion yuan or 0.19% from the previous day [1] - The Shenzhen market's ETF margin balance is 31.904 billion yuan, increasing by 2.44 million yuan, while the Shanghai market's balance is 68.243 billion yuan, decreasing by 4.18 billion yuan [1] Group 2: Specific ETF Financing Balances - The top three ETFs by financing balance are: - Huaan Gold ETF with 7.453 billion yuan - E Fund Gold ETF with 6.253 billion yuan - Huaxia Hang Seng ETF with 4.232 billion yuan [2] - The ETFs with the highest increase in financing balance include: - Penghua CSI 300 ETF with an increase of 8331.75% - Wanji Zhongzheng A500 ETF with an increase of 2384.62% - CSI 500 ETF with an increase of 1814.58% [2] Group 3: Margin Trading and Short Selling - The latest short selling balance for ETFs shows significant changes, with the highest increase in short selling being for Guangfa Solar 50 ETF, which increased by 16666.67% [5] - The top three ETFs by short selling balance are: - Southern CSI 1000 ETF with 2.1107418 billion yuan - Guangfa CSI 1000 ETF with 386.4118 million yuan - Huaxia CSI 1000 ETF with 374.5804 million yuan [6] Group 4: Net Buying and Selling of ETFs - The ETFs with the highest net buying amounts are: - E Fund ChiNext ETF with 229.45 million yuan - Southern CSI 500 ETF with 221.48 million yuan - E Fund Hong Kong Securities Investment Theme ETF with 190.98 million yuan [4] - The ETFs with the highest net selling amounts include: - Fuguo Zhongdai 7-10 Year Policy Financial Bond ETF with 703 million yuan - Guotai CSI 5-Year National Bond ETF with 75.117 million yuan - Guangfa Zhongzheng Hong Kong Innovative Medicine ETF with 73.2018 million yuan [4]